nodes	percent_of_prediction	percent_of_DWPC	metapath
Lansoprazole—ABCG2—Cyclosporine—focal segmental glomerulosclerosis	0.212	0.306	CbGbCtD
Lansoprazole—CYP2C8—Cyclosporine—focal segmental glomerulosclerosis	0.113	0.163	CbGbCtD
Lansoprazole—CYP2C19—Cyclosporine—focal segmental glomerulosclerosis	0.0948	0.137	CbGbCtD
Lansoprazole—CYP2C9—Cyclosporine—focal segmental glomerulosclerosis	0.0788	0.114	CbGbCtD
Lansoprazole—ABCB1—Cyclosporine—focal segmental glomerulosclerosis	0.0765	0.11	CbGbCtD
Lansoprazole—CYP2D6—Cyclosporine—focal segmental glomerulosclerosis	0.072	0.104	CbGbCtD
Lansoprazole—CYP3A4—Cyclosporine—focal segmental glomerulosclerosis	0.0458	0.0661	CbGbCtD
Lansoprazole—Tonsillitis—Cyclosporine—focal segmental glomerulosclerosis	0.00714	0.0267	CcSEcCtD
Lansoprazole—MAPT—nephron tubule—focal segmental glomerulosclerosis	0.00657	0.164	CbGeAlD
Lansoprazole—Thrombotic thrombocytopenic purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00631	0.0236	CcSEcCtD
Lansoprazole—Pharyngeal oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00631	0.0236	CcSEcCtD
Lansoprazole—Carcinoma—Cyclosporine—focal segmental glomerulosclerosis	0.00597	0.0224	CcSEcCtD
Lansoprazole—Skin cancer—Cyclosporine—focal segmental glomerulosclerosis	0.00582	0.0218	CcSEcCtD
Lansoprazole—MAPT—cortex of kidney—focal segmental glomerulosclerosis	0.00563	0.141	CbGeAlD
Lansoprazole—Eye swelling—Cyclosporine—focal segmental glomerulosclerosis	0.00554	0.0207	CcSEcCtD
Lansoprazole—CYP4A11—kidney—focal segmental glomerulosclerosis	0.00532	0.133	CbGeAlD
Lansoprazole—CYP4A11—cortex of kidney—focal segmental glomerulosclerosis	0.00518	0.13	CbGeAlD
Lansoprazole—Goitre—Cyclosporine—focal segmental glomerulosclerosis	0.00505	0.0189	CcSEcCtD
Lansoprazole—ATP4A—kidney—focal segmental glomerulosclerosis	0.00429	0.107	CbGeAlD
Lansoprazole—Leukorrhea—Cyclosporine—focal segmental glomerulosclerosis	0.00385	0.0144	CcSEcCtD
Lansoprazole—Bursitis—Cyclosporine—focal segmental glomerulosclerosis	0.00373	0.014	CcSEcCtD
Lansoprazole—Myositis—Cyclosporine—focal segmental glomerulosclerosis	0.00368	0.0138	CcSEcCtD
Lansoprazole—Ear disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00334	0.0125	CcSEcCtD
Lansoprazole—Urine abnormality—Cyclosporine—focal segmental glomerulosclerosis	0.00326	0.0122	CcSEcCtD
Lansoprazole—Gingival bleeding—Cyclosporine—focal segmental glomerulosclerosis	0.00318	0.0119	CcSEcCtD
Lansoprazole—Micturition urgency—Cyclosporine—focal segmental glomerulosclerosis	0.00318	0.0119	CcSEcCtD
Lansoprazole—Multiple fractures—Cyclosporine—focal segmental glomerulosclerosis	0.0031	0.0116	CcSEcCtD
Lansoprazole—Fracture—Cyclosporine—focal segmental glomerulosclerosis	0.0031	0.0116	CcSEcCtD
Lansoprazole—Urine analysis abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00307	0.0115	CcSEcCtD
Lansoprazole—Polyp—Cyclosporine—focal segmental glomerulosclerosis	0.00297	0.0111	CcSEcCtD
Lansoprazole—Libido increased—Cyclosporine—focal segmental glomerulosclerosis	0.00297	0.0111	CcSEcCtD
Lansoprazole—Vaginal discharge—Cyclosporine—focal segmental glomerulosclerosis	0.00297	0.0111	CcSEcCtD
Lansoprazole—Optic neuritis—Cyclosporine—focal segmental glomerulosclerosis	0.00293	0.011	CcSEcCtD
Lansoprazole—Folliculitis—Cyclosporine—focal segmental glomerulosclerosis	0.00287	0.0107	CcSEcCtD
Lansoprazole—Hypomagnesaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00284	0.0106	CcSEcCtD
Lansoprazole—Tooth disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00278	0.0104	CcSEcCtD
Lansoprazole—Nail disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00278	0.0104	CcSEcCtD
Lansoprazole—Menstrual disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00265	0.00991	CcSEcCtD
Lansoprazole—Interstitial lung disease—Cyclosporine—focal segmental glomerulosclerosis	0.00255	0.00955	CcSEcCtD
Lansoprazole—Hyperlipidaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0025	0.00937	CcSEcCtD
Lansoprazole—Tongue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00248	0.00929	CcSEcCtD
Lansoprazole—Herpes zoster—Cyclosporine—focal segmental glomerulosclerosis	0.0024	0.00897	CcSEcCtD
Lansoprazole—Hepatotoxicity—Cyclosporine—focal segmental glomerulosclerosis	0.00234	0.00875	CcSEcCtD
Lansoprazole—Neoplasm malignant—Cyclosporine—focal segmental glomerulosclerosis	0.00211	0.00791	CcSEcCtD
Lansoprazole—Breast pain—Cyclosporine—focal segmental glomerulosclerosis	0.00207	0.00774	CcSEcCtD
Lansoprazole—Musculoskeletal stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.00201	0.00753	CcSEcCtD
Lansoprazole—Rectal haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.002	0.00748	CcSEcCtD
Lansoprazole—Viral infection—Cyclosporine—focal segmental glomerulosclerosis	0.002	0.00748	CcSEcCtD
Lansoprazole—Hyperbilirubinaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00198	0.00743	CcSEcCtD
Lansoprazole—Dysmenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00198	0.00743	CcSEcCtD
Lansoprazole—Arthropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00198	0.00743	CcSEcCtD
Lansoprazole—Glossitis—Cyclosporine—focal segmental glomerulosclerosis	0.00196	0.00733	CcSEcCtD
Lansoprazole—CYP1B1—nephron tubule—focal segmental glomerulosclerosis	0.00194	0.0486	CbGeAlD
Lansoprazole—Gout—Cyclosporine—focal segmental glomerulosclerosis	0.00193	0.00724	CcSEcCtD
Lansoprazole—Cataract—Cyclosporine—focal segmental glomerulosclerosis	0.0019	0.0071	CcSEcCtD
Lansoprazole—Creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.0019	0.0071	CcSEcCtD
Lansoprazole—Hiccups—Cyclosporine—focal segmental glomerulosclerosis	0.0018	0.00676	CcSEcCtD
Lansoprazole—Eructation—Cyclosporine—focal segmental glomerulosclerosis	0.00177	0.00664	CcSEcCtD
Lansoprazole—Candida infection—Cyclosporine—focal segmental glomerulosclerosis	0.00172	0.00645	CcSEcCtD
Lansoprazole—CYP1B1—kidney—focal segmental glomerulosclerosis	0.00171	0.0427	CbGeAlD
Lansoprazole—Blood urea increased—Cyclosporine—focal segmental glomerulosclerosis	0.0017	0.00638	CcSEcCtD
Lansoprazole—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00169	0.00634	CcSEcCtD
Lansoprazole—CYP1B1—cortex of kidney—focal segmental glomerulosclerosis	0.00166	0.0416	CbGeAlD
Lansoprazole—Cramps of lower extremities—Cyclosporine—focal segmental glomerulosclerosis	0.00166	0.00621	CcSEcCtD
Lansoprazole—Oesophagitis—Cyclosporine—focal segmental glomerulosclerosis	0.00165	0.00617	CcSEcCtD
Lansoprazole—Urine output increased—Cyclosporine—focal segmental glomerulosclerosis	0.00163	0.00611	CcSEcCtD
Lansoprazole—Gynaecomastia—Cyclosporine—focal segmental glomerulosclerosis	0.00161	0.00605	CcSEcCtD
Lansoprazole—Abnormal vision—Cyclosporine—focal segmental glomerulosclerosis	0.00157	0.00589	CcSEcCtD
Lansoprazole—Lymphadenopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00154	0.00575	CcSEcCtD
Lansoprazole—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.00151	0.00564	CcSEcCtD
Lansoprazole—Polyuria—Cyclosporine—focal segmental glomerulosclerosis	0.00149	0.00559	CcSEcCtD
Lansoprazole—Gastroenteritis—Cyclosporine—focal segmental glomerulosclerosis	0.00148	0.00553	CcSEcCtD
Lansoprazole—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00146	0.00548	CcSEcCtD
Lansoprazole—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.00146	0.00548	CcSEcCtD
Lansoprazole—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.00145	0.00543	CcSEcCtD
Lansoprazole—ABCG2—nephron tubule—focal segmental glomerulosclerosis	0.00145	0.0362	CbGeAlD
Lansoprazole—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.00142	0.00534	CcSEcCtD
Lansoprazole—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00141	0.00529	CcSEcCtD
Lansoprazole—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.0014	0.00524	CcSEcCtD
Lansoprazole—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00139	0.00522	CcSEcCtD
Lansoprazole—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.00139	0.0052	CcSEcCtD
Lansoprazole—Renal impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00138	0.00515	CcSEcCtD
Lansoprazole—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00136	0.00509	CcSEcCtD
Lansoprazole—Anaphylactoid reaction—Cyclosporine—focal segmental glomerulosclerosis	0.00135	0.00507	CcSEcCtD
Lansoprazole—Arthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00135	0.00505	CcSEcCtD
Lansoprazole—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00134	0.00503	CcSEcCtD
Lansoprazole—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00131	0.0049	CcSEcCtD
Lansoprazole—CYP2C8—kidney—focal segmental glomerulosclerosis	0.00131	0.0327	CbGeAlD
Lansoprazole—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.0013	0.00487	CcSEcCtD
Lansoprazole—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.00129	0.00483	CcSEcCtD
Lansoprazole—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.00129	0.00483	CcSEcCtD
Lansoprazole—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.00124	0.00465	CcSEcCtD
Lansoprazole—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00123	0.00459	CcSEcCtD
Lansoprazole—CYP1A1—kidney—focal segmental glomerulosclerosis	0.00121	0.0302	CbGeAlD
Lansoprazole—Dry skin—Cyclosporine—focal segmental glomerulosclerosis	0.0012	0.0045	CcSEcCtD
Lansoprazole—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00118	0.00443	CcSEcCtD
Lansoprazole—Cramp muscle—Cyclosporine—focal segmental glomerulosclerosis	0.00118	0.00442	CcSEcCtD
Lansoprazole—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.00116	0.00434	CcSEcCtD
Lansoprazole—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.00116	0.00433	CcSEcCtD
Lansoprazole—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.00114	0.00427	CcSEcCtD
Lansoprazole—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.00113	0.00424	CcSEcCtD
Lansoprazole—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00111	0.00416	CcSEcCtD
Lansoprazole—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.00109	0.00408	CcSEcCtD
Lansoprazole—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00109	0.00406	CcSEcCtD
Lansoprazole—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.00106	0.00396	CcSEcCtD
Lansoprazole—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00105	0.00394	CcSEcCtD
Lansoprazole—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.00105	0.00392	CcSEcCtD
Lansoprazole—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00103	0.00386	CcSEcCtD
Lansoprazole—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00102	0.00382	CcSEcCtD
Lansoprazole—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.00102	0.0038	CcSEcCtD
Lansoprazole—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.00378	CcSEcCtD
Lansoprazole—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.00101	0.00378	CcSEcCtD
Lansoprazole—Acute coronary syndrome—Cyclosporine—focal segmental glomerulosclerosis	0.000995	0.00373	CcSEcCtD
Lansoprazole—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.000992	0.00372	CcSEcCtD
Lansoprazole—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.000989	0.0037	CcSEcCtD
Lansoprazole—Myocardial infarction—Cyclosporine—focal segmental glomerulosclerosis	0.000989	0.0037	CcSEcCtD
Lansoprazole—Jaundice—Cyclosporine—focal segmental glomerulosclerosis	0.000984	0.00368	CcSEcCtD
Lansoprazole—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000984	0.00368	CcSEcCtD
Lansoprazole—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.000981	0.00367	CcSEcCtD
Lansoprazole—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.000981	0.00367	CcSEcCtD
Lansoprazole—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.000962	0.0036	CcSEcCtD
Lansoprazole—Hepatobiliary disease—Cyclosporine—focal segmental glomerulosclerosis	0.000955	0.00357	CcSEcCtD
Lansoprazole—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.000952	0.00356	CcSEcCtD
Lansoprazole—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.000947	0.00355	CcSEcCtD
Lansoprazole—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.000908	0.0034	CcSEcCtD
Lansoprazole—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000906	0.00339	CcSEcCtD
Lansoprazole—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000902	0.00338	CcSEcCtD
Lansoprazole—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.000899	0.00337	CcSEcCtD
Lansoprazole—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000895	0.00335	CcSEcCtD
Lansoprazole—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00089	0.00333	CcSEcCtD
Lansoprazole—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000888	0.00333	CcSEcCtD
Lansoprazole—CYP3A4—kidney—focal segmental glomerulosclerosis	0.000886	0.0222	CbGeAlD
Lansoprazole—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.000873	0.00327	CcSEcCtD
Lansoprazole—CYP2D6—kidney—focal segmental glomerulosclerosis	0.000872	0.0218	CbGeAlD
Lansoprazole—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.000845	0.00316	CcSEcCtD
Lansoprazole—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.000822	0.00308	CcSEcCtD
Lansoprazole—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000817	0.00306	CcSEcCtD
Lansoprazole—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.000813	0.00304	CcSEcCtD
Lansoprazole—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.000809	0.00303	CcSEcCtD
Lansoprazole—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.000801	0.003	CcSEcCtD
Lansoprazole—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000794	0.00297	CcSEcCtD
Lansoprazole—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.000789	0.00295	CcSEcCtD
Lansoprazole—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.000777	0.00291	CcSEcCtD
Lansoprazole—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.000774	0.0029	CcSEcCtD
Lansoprazole—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.000772	0.00289	CcSEcCtD
Lansoprazole—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.000766	0.00287	CcSEcCtD
Lansoprazole—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.000758	0.00284	CcSEcCtD
Lansoprazole—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.000743	0.00278	CcSEcCtD
Lansoprazole—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.000739	0.00277	CcSEcCtD
Lansoprazole—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000732	0.00274	CcSEcCtD
Lansoprazole—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.000729	0.00273	CcSEcCtD
Lansoprazole—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.000725	0.00271	CcSEcCtD
Lansoprazole—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.000721	0.0027	CcSEcCtD
Lansoprazole—ABCB1—nephron tubule—focal segmental glomerulosclerosis	0.000714	0.0178	CbGeAlD
Lansoprazole—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.000711	0.00266	CcSEcCtD
Lansoprazole—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.000709	0.00265	CcSEcCtD
Lansoprazole—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.000706	0.00264	CcSEcCtD
Lansoprazole—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.000688	0.00258	CcSEcCtD
Lansoprazole—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.000683	0.00256	CcSEcCtD
Lansoprazole—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.000681	0.00255	CcSEcCtD
Lansoprazole—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.000672	0.00251	CcSEcCtD
Lansoprazole—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.000672	0.00251	CcSEcCtD
Lansoprazole—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.000672	0.00251	CcSEcCtD
Lansoprazole—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.000669	0.00251	CcSEcCtD
Lansoprazole—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.000667	0.0025	CcSEcCtD
Lansoprazole—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000663	0.00248	CcSEcCtD
Lansoprazole—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.000657	0.00246	CcSEcCtD
Lansoprazole—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.000649	0.00243	CcSEcCtD
Lansoprazole—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.000644	0.00241	CcSEcCtD
Lansoprazole—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.000644	0.00241	CcSEcCtD
Lansoprazole—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00064	0.00239	CcSEcCtD
Lansoprazole—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000631	0.00236	CcSEcCtD
Lansoprazole—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00063	0.00236	CcSEcCtD
Lansoprazole—ABCB1—kidney—focal segmental glomerulosclerosis	0.000627	0.0157	CbGeAlD
Lansoprazole—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000625	0.00234	CcSEcCtD
Lansoprazole—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.000622	0.00233	CcSEcCtD
Lansoprazole—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.000614	0.0023	CcSEcCtD
Lansoprazole—ABCB1—cortex of kidney—focal segmental glomerulosclerosis	0.000611	0.0153	CbGeAlD
Lansoprazole—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.000587	0.0022	CcSEcCtD
Lansoprazole—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.000582	0.00218	CcSEcCtD
Lansoprazole—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.000578	0.00216	CcSEcCtD
Lansoprazole—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.000574	0.00215	CcSEcCtD
Lansoprazole—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.000572	0.00214	CcSEcCtD
Lansoprazole—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.000567	0.00212	CcSEcCtD
Lansoprazole—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00056	0.0021	CcSEcCtD
Lansoprazole—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.000556	0.00208	CcSEcCtD
Lansoprazole—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.000555	0.00208	CcSEcCtD
Lansoprazole—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00055	0.00206	CcSEcCtD
Lansoprazole—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00055	0.00206	CcSEcCtD
Lansoprazole—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00053	0.00199	CcSEcCtD
Lansoprazole—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000526	0.00197	CcSEcCtD
Lansoprazole—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.000511	0.00191	CcSEcCtD
Lansoprazole—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.000509	0.00191	CcSEcCtD
Lansoprazole—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.000509	0.00191	CcSEcCtD
Lansoprazole—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.000474	0.00178	CcSEcCtD
Lansoprazole—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.000462	0.00173	CcSEcCtD
Lansoprazole—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.000455	0.00171	CcSEcCtD
Lansoprazole—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00044	0.00165	CcSEcCtD
Lansoprazole—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.000426	0.00159	CcSEcCtD
Lansoprazole—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.000409	0.00153	CcSEcCtD
Lansoprazole—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.000406	0.00152	CcSEcCtD
Lansoprazole—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.000406	0.00152	CcSEcCtD
Lansoprazole—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.000403	0.00151	CcSEcCtD
Lansoprazole—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.000382	0.00143	CcSEcCtD
